Pharma Co. Faces Investor Suit Over $1.8B AstraZeneca Deal
By Emilie Ruscoe ( January 23, 2023, 9:02 PM EST) -- An investor in biopharmaceutical company CinCor Pharma Inc. has alleged there were misrepresentations in a document that detailed a proposed acquisition of CinCor worth up to $1.8 billion by European pharmaceutical company AstraZeneca PLC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.